SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-15-043213
Filing Date
2015-07-20
Accepted
2015-07-20 10:25:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v415796_sc13g.htm SC 13G 44486
  Complete submission text file 0001144204-15-043213.txt   46074
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Subject) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87827 | Film No.: 15995298
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 GREAT NECK ROAD SUITE 214 GREAT NECK NY 11021
Business Address 111 GREAT NECK ROAD SUITE 214 GREAT NECK NY 11021 5164989890
VIS VIRES GROUP, INC. (Filed by) CIK: 0001641515 (see all company filings)

IRS No.: 472303658 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G